Florida Woman Charges Life-Threatening Blood Clot Caused by Yaz Birth Control Drug According to Lieff Cabraser Heimann & Bernstein, LLP
NEW YORK, Aug. 23, 2011 /PRNewswire/ --
Wendy R. Fleishman of the national plaintiffs' law firm Lieff Cabraser Heimann & Bernstein, LLP announced that Tiffany Littles, 33, of Jacksonville, Florida, filed a personal injury lawsuit against Bayer Healthcare Pharmaceuticals, Inc., for severe and lasting injuries caused by Bayer's birth control drug Yaz. Littles' complaint charges that Yaz is a dangerous prescription drug sold without adequate warnings about the risk of serious injuries.
In July 2008, Littles suffered a bilateral pulmonary emboli, cor pulmonale, and deep vein thrombosis ("DVT"), more commonly known as a blood clot. If left untreated, blood clots can break off and result in life-threatening conditions.
"I am bringing this lawsuit so that this traumatic event does not happen to anyone else," stated Littles. "I nearly died from taking this medication--the hospital even brought in a priest for me."
The complaint charges that Littles would not have been injured had Bayer properly warned patients of the dangers of using Yaz.
"The FDA's adverse event database for Yaz and Yasmin reveal a very high number of serious adverse events associated with these drugs, including strokes, heart attacks, blood clot formation, and sometimes death," commented attorney Fleishman. "Bayer failed to warn doctors and consumers, we allege, that Yaz and Yasmin pose a greater risk of serious injuries than earlier generation oral contraceptives."
The complaint was filed yesterday afternoon in the Philadelphia Court of Common Pleas.
For more information, please visit our Yaz birth control lawsuit page.
Yaz and Yasmin are registered trademarks of Bayer Schering Pharma Aktiengesellschaft and used for informational and product identification purposes only.
Source | Contact
Wendy R. Fleishman/Paulina do Amaral
Lieff Cabraser Heimann & Bernstein, LLP
SOURCE Lieff Cabraser Heimann & Bernstein, LLP